Bempegaldesleukin
18-214-10
Phase 2 mab completed
Quick answer
Bempegaldesleukin for Urinary Bladder Neoplasm is a Phase 2 program (mab) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Urinary Bladder Neoplasm
- Phase
- Phase 2
- Modality
- mab
- Status
- completed